SkinBioTherapeutics plc (FRA:5KW)

Germany flag Germany · Delayed Price · Currency is EUR
0.173
0.00 (0.00%)
Last updated: Dec 4, 2025, 8:00 AM CET
-17.62%
Market Cap 49.26M
Revenue (ttm) 3.24M
Net Income (ttm) -3.11M
Shares Out n/a
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.173
Previous Close 0.173
Day's Range 0.173 - 0.173
52-Week Range 0.142 - 0.312
Beta n/a
RSI 58.60
Earnings Date Dec 2, 2025

About SkinBioTherapeutics

SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2015
Employees 15
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5KW
Full Company Profile

Financial Performance

In 2025, SkinBioTherapeutics's revenue was 4.64 million, an increase of 283.74% compared to the previous year's 1.21 million. Losses were -696,253, -75.79% less than in 2024.

Financial numbers in GBP Financial Statements

News

There is no news available yet.